Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12173-12180

  Park, In Hae ^a,b   Kang, Joo Hyun ^a   Lee, Keun Seok ^a   Nam, Seungyoon ^a   Ro, Jungsil ^a   Kim, Joo Hang ^b  

^a National Cancer Center   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Biomarker; Breast cancer; Cancer associated microRNAs; Circulating microRNA; tRNA derived fragment

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 10A; MICRORNA 125B; MICRORNA 1260; MICRORNA 1268; MICRORNA 1274A; MICRORNA 1274B; MICRORNA 1280; MICRORNA 1308; MICRORNA 138; MICRORNA 139 3P; MICRORNA 144; MICRORNA 145; MICRORNA 15B; MICRORNA 181A; MICRORNA 195; MICRORNA 200C; MICRORNA 21; MICRORNA 212; MICRORNA 222; MICRORNA 30A; MICRORNA 487B; MICRORNA 571; MICRORNA 654 3P; MICRORNA 708; MICRORNA 720; MICRORNA 886 3P; MICRORNA 93; MICRORNA LET 7A; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC THERAPY; TREATMENT RESPONSE; UPREGULATION; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; CHEMISTRY; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; NUCLEOTIDE SEQUENCE; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RECEPTORS, ESTROGEN; TREATMENT OUTCOME;

EID: 84925285682     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2525-5     Document Type: Article

References (29)

1. Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–69.
2. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.
3. Iorio M, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65(16):7065–70.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–8.
5. Garzon R, Calin G, Croce C. MicroRNAs in cancer. Annu Rev Med. 2009;60:167–79.
6. Garzon R, Marcucci G, Croce C. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9(10):775–89.
7. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207(2):243–9.
8. Chan J, Krichevsky A, Kosik K. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029–33.
9. Ventura A, Young A, Winslow M, Lintault L, Meissner A, Erkeland S, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132(5):875–86.
10. Lowery A, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 2009;11(3):R27.
11. Blenkiron C, Goldstein L, Thorne N, Spiteri I, Chin S-F, Dunning M, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007;8(10):R214.
12. Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A. 2007;104(51):20350–5.
13. Shimono Y, Zabala M, Cho R, Lobo N, Dalerba P, Qian D, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009;138(3):592–603.
14. Shenouda S, Alahari S. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 2009;28(3–4):369–78.
15. Mitchell P, Parkin R, Kroh E, Fritz B, Wyman S, Pogosova-Agadjanyan E, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–8.
16. Heneghan H, Miller N, Lowery A. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010;251(3):499–505.
17. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010;102(7):1174–9.
18. Wong T-S, Liu X-B, Wong B. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14(9):2588–92.
19. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28(10):1721–6.
20. Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, et al. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One. 2012;7(10):e47003.
21. Zhao H, Shen J, Medico L, Wang D, Ambrosone C. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5(10):e13735.
22. Comparison of microRNA expression with whole blood between ER positive breast cancer patients and normal controls. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53179.
23. Schopman NC, Heynen S, Haasnoot J, Berkhout B. A miRNA-tRNA mix-up: tRNA origin of proposed miRNA. RNA Biol. 2010;7(5):573–6.
24. Cheloufi S, Dos Santos C, Chong M, Hannon G. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature. 2010;465(7298):584–9.
25. Yang J, Lai E. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell. 2011;43(6):892–903.
26. Lee Y, Shibata Y, Malhotra A, Dutta A. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 2009;23(22):2639–49.
27. Maute RL, Schneider C, Sumazin P, Holmes A, Califano A, Basso K, et al. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc Natl Acad Sci U S A. 2013;110(4):1404–9.
28. Chan M, Liaw C, Ji S, Tan H, Wong C, Thike A, et al. Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res. 2013;19(16):4477–87.
29. Jung E-J, Santarpia L, Kim J, Esteva F, Moretti E, Buzdar A, et al. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer. 2012;118(10):2603–14.